-
Signature
-
Farinaz S. Tehrani, Attorney-in-Fact
-
Issuer symbol
-
VSEC
-
Transactions as of
-
08 Mar 2024
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
12 Mar 2024, 16:11:45 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VSEC |
Common Stock |
Options Exercise |
|
+1,310 |
+5.9% |
|
23,667 |
10 Mar 2024 |
Direct |
F1, F2 |
| transaction |
VSEC |
Common Stock |
Award |
$0 |
+3,639 |
+15% |
$0.000000 |
27,306 |
10 Mar 2024 |
Direct |
F3 |
| transaction |
VSEC |
Common Stock |
Options Exercise |
|
+1,072 |
+3.9% |
|
28,378 |
11 Mar 2024 |
Direct |
F2, F4 |
| transaction |
VSEC |
Common Stock |
Award |
$0 |
+1,473 |
+5.2% |
$0.000000 |
29,851 |
11 Mar 2024 |
Direct |
F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VSEC |
Restricted Stock Units |
Award |
$0 |
+2,933 |
|
$0.000000 |
2,933 |
08 Mar 2024 |
Common Stock |
2,933 |
|
Direct |
F2, F6 |
| transaction |
VSEC |
Restricted Stock Units |
Options Exercise |
$0 |
-1,310 |
-33% |
$0.000000 |
2,621 |
10 Mar 2024 |
Common Stock |
1,310 |
|
Direct |
F2, F7 |
| transaction |
VSEC |
Restricted Stock Units |
Options Exercise |
$0 |
-1,072 |
-50% |
$0.000000 |
1,072 |
11 Mar 2024 |
Common Stock |
1,072 |
|
Direct |
F2, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: